Drug Database
Back to search

Netherlands· NL-feae97bacad8

Cholecomb 10 mg/10 mg, capsule, hard

A rosuvastatin and ezetimibe product containing ezetimib + rosuvastatine zink, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC C10BA06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCholecomb 10 mg/10 mg, capsule, hardATCC10BA06REGISTER NO.NL-feae97bacad8PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ezetimib + rosuvastatine zinkAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rosuvastatin and ezetimibe is registered in 9 of 19 countries.

Countries holding a registration under ATC C10BA06 (rosuvastatin and ezetimibe), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search rosuvastatin and ezetimibe products by name

Rosuvastatin and ezetimibe · ATC C10BA06

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
EZETIMIB + ROSUVASTATINE ZINK
Manufacturer
Medcor Pharmaceuticals B.V.
Country
Netherlands (NL)
ATC code
C10BA06
ATC class
Rosuvastatin and ezetimibe
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    130422//114005

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under C10BA06

Rosuvastatin and ezetimibe, as other registers publish it.

All rosuvastatin and ezetimibe products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac805eaa-67db-4533-9a78-d2b6f17c24a8
GET /v1/drugs/ac805eaa-67db-4533-9a78-d2b6f17c24a8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h114005_smpc.pdf",
  "strength": null,
  "atc_label": "Rosuvastatin and ezetimibe",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130422",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GELATINE (E 441)",
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "IJZEROXIDE GEEL (E 172)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "NATRIUMLAURILSULFAAT",
    "POVIDON K 25 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "EZETIMIB",
    "ROSUVASTATINE ZINK"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130422.pdf",
  "authorised_at": "2023/02/28",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130422//114005",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about rosuvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console